If no other option help...
Key Market Indicator:
F&G: 63
25.547,95 NASDAQ · 49.390,00 DOW · 6.947,26 S&P · 4.596,86 Gold · 63,45 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
© ACCESSWIRE
06.01.2026
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Expands Into JFK Airport Through Landmark Mother Earth Juice Bar Partnership in New York
News Preview
With the global pain management market projected to exceed $110 billion by 2030 and hemp-derived topical products continuing to post double-digit annual growth, CBD Life Sciences is accelerating its expansion into premium, high-traffic retail environments nationwide. SCOTTSDALE, ARIZONA / ACCESS Newswire / January 6, 2026 / CBD Life Sciences Inc. (...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
02.12.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) CEO Lisa Nelson Interviews With The Morning Show
News Preview
"Inside the explosive rise of a wellness company outpacing a $200B+ global market"Watch the full Morning Show interview → SCOTTSDALE, ARIZONA / ACCESS Newswire / December 2, 2025 / CBD Life Sciences Inc. (OTCID:CBDL) is gaining powerful investor momentum this week following a spotlight interview with CEO Lisa Nelson on The Mornin...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
18.11.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Secures Exclusive Launch of New Anti-Inflammatory "Soothe Gel" Across Two Red Hots Spa Locations in New York
News Preview
With the global pain-management market projected to surpass $93.9 billion by 2030 and topical analgesics growing at a 7.2% CAGR, CBDL positions itself for major East Coast expansion amid surging consumer demand for natural relief solutions. SCOTTSDALE, AZ / ACCESS Newswire / November 18, 2025 / CBD Life Sciences Inc. (OTC:CBDL), the parent company...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar

USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© ACCESSWIRE
12.11.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Secures Major Hemp Flower Order From Bronx Dispensary Smoking Scholars Amid Explosive Growth
News Preview
With a staggering 1405.46% revenue surge since February 2024, CBDL continues its explosive expansion as Smoking Scholars places another major order in New York's $7.2 billion cannabis market. SCOTTSDALE, ARIZONA / ACCESS Newswire / November 12, 2025 / CBD Life Sciences Inc. (OTC Pink:CBDL) proudly announces another significant order from Smoking Sc...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© ACCESSWIRE
28.10.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (OTC: CBDL) Launches Tremendous Energy & Weight-Loss Diet Hemp-Free Gummies
News Preview
Global functional gummy supplements market projected to surpass $50 billion by 2030 - CBDL expands into two of the fastest-growing segments in wellness and performance nutrition. SCOTTSDALE, ARIZONA / ACCESS Newswire / October 28, 2025 / CBD Life Sciences Inc. (OTC:CBDL), an emerging leader in wellness innovation and nutraceutical advancement, prou...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
21.10.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Launches First-of-Its-Kind Mushroom-Infused "Dubai Chocolate Bar"
News Preview
Dubai's luxury chocolate market-valued at over $1.5 billion and growing 6.8% annually-meets the $35 billion global mushroom supplement boom, creating a major new revenue stream for CBDL. SCOTTSDALE, ARIZONA / ACCESS Newswire / October 21, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), through its wholly owned subsidiary CBD Vault, is proud to annou...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.10.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Lands Major Order from Bronx Dispensary "Smoking Scholars," Signaling Explosive Growth Ahead for CBD-Infused Drinks Division
News Preview
Strong consumer demand and rapid market adoption drive CBDL's beverage expansion as top-selling CBD Lemonade, Raspberry Lemonade, and Lavender Lemonade hit the shelves of Smoking Scholars in New York City - setting the stage for record-breaking revenue in Q4 and beyond. SCOTTSDALE, AZ, AZ / ACCESS Newswire / October 14, 2025 / CBD Life Sciences Inc...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
30.09.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Secures Landmark Agreement with Bronx Powerhouse Dispensary Smoking Scholars
News Preview
With New York dispensaries projected to surpass $4.4 billion in annual sales by 2027, CBDL secures a transformative partnership poised to generate multi-million-dollar revenues and accelerate nationwide expansion. SCOTTSDALE, AZ / ACCESS Newswire / September 30, 2025 / CBD Life Sciences Inc. (OTC:CBDL), through its operating subsidiary CBD Vault, t...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
23.09.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Announces LOI With New Jersey Dispensary, Unlocking New Revenue Channels & Strategic Growth Opportunities
News Preview
Strategic collaboration expands CBDL's footprint in the booming East Coast cannabis market projected to surpass $33 billion by 2030, while strengthening retail distribution and cross-brand synergies SCOTTSDALE, AZ / ACCESS Newswire / September 23, 2025 / CBD Life Sciences Inc. (OTC:CBDL), through its wholly owned subsidiary, CBD Vault, is proud to...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
16.09.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Huge Momentum Following NECANN New Jersey 2025
News Preview
The U.S. marijuana dispensary market is projected to generate over $31.8 billion annually by 2025, creating multi-million-dollar opportunities for CBDL through dispensary partnerships and large-scale beverage distribution in sports stadiums nationwide. SCOTTSDALE, ARIZONA / ACCESS Newswire / September 16, 2025 / CBD Life Sciences Inc. (OTC:CBDL), t...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.09.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Announces President Trump Confirms Marijuana Rescheduling Is Under Consideration
News Preview
"A shift to Schedule III could unlock a $30+ billion market, eliminate crippling 280E tax burdens, unleash institutional investment, and set the stage for explosive industry-wide growth." SCOTTSDALE, ARIZONA / ACCESS Newswire / September 3, 2025 / CBD Life Sciences Inc. (OTC:CBDL), a leader in the development and sale of high-quality CBD...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.08.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Announces Company Will Exhibit at the NECANN Cannabis Conference in Atlantic City, NJ
News Preview
NECANN New Jersey attracts over 5,000 industry leaders, features more than 200 exhibitors, and is ranked the 3rd largest B2B cannabis convention in the United States - positioning CBDL for unprecedented growth, revenue opportunities, and investor value. SCOTTSDALE, ARIZONA / ACCESS Newswire / August 27, 2025 / CBD Life Sciences Inc. (OTC:CBDL), a t...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© ACCESSWIRE
05.08.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Announces National Expansion into Las Vegas Resorts & Hotels
News Preview
Las Vegas CBD market projected to surpass $550 million by 2026, driven by tourism, retail, and wellness integration SCOTTSDALE, AZ / ACCESS Newswire / August 5, 2025 / CBD Life Sciences Inc. (OTC:CBDL), a leading innovator in the cannabidiol and wellness product space, is proud to announce a major development in its national expansion strategy, as...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.07.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Nears Final Lease Agreement for Second High-Traffic Retail Location in Premier Arizona Mall, Signaling Major Expansion Phase
News Preview
U.S. CBD market projected to exceed $36 billion by 2032 as foot traffic rebounds in top-tier malls with over 122 million monthly U.S. shoppers - CBDL strategically positioned at the intersection of both trends SCOTTSDALE, ARIZONA / ACCESS Newswire / July 29, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), an emerging leader in the cannabinoid and al...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
08.07.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBDL Announces Strategic Rollout on Vibe Performance Network, Elevating 8000MG Pain Cream to National Streaming Audiences
News Preview
CBD Life Sciences Inc. (OTC:CBDL) expands its digital advertising arsenal through the Vibe Performance Network, positioning its flagship 8000MG Pain Cream in front of millions of engaged, wellness-focused viewers - unlocking massive revenue potential and long-term shareholder value in the booming CBD market. SCOTTSDALE, ARIZONA / ACCESS Newswire /...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
11.06.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Reports 1,502.30% Revenue Increase from January to May 2025
News Preview
Achieving a five-month revenue growth equivalent to an annualized rate exceeding 4,000%, as the booming CBD and mushroom supplement markets-projected to reach $30 billion and $15 billion respectively by 2028-fuel strong consumer demand and industry expansion. SCOTTSDALE, AZ / ACCESS Newswire / June 11, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL),...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.06.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Releases New CBD Suppositories for Vaginal & Rectal Relief
News Preview
CBDL Enters the $2.8 Billion Suppository Market with a First-of-Its-Kind Product - Tapping a High-Demand, Low-Competition Sector Poised for Transformational Growth SCOTTSDALE, AZ / ACCESS Newswire / June 3, 2025 / CBD Life Sciences Inc. (OTC Pink:CBDL), a leader in the CBD wellness industry, proudly announces the launch of its groundbreaking line o...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
06.05.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Southwest-Based Company
News Preview
Strategic alliance positions CBDL for aggressive national growth through 100+ retail locations and new premium product lines SCOTTSDALE, AZ / ACCESS Newswire / May 6, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a leading innovator in the CBD health and wellness space, is proud to announce a new strategic manufacturing partnership with Jeannie in...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.04.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Announces New Manufacturing Deal With A Columbian Company
News Preview
New manufacturing deal positions CBDL to tap into the $4.9 billion Latin American CBD market, unlocking major revenue growth and accelerating international expansion. SCOTTSDALE, ARIZONA / ACCESS Newswire / April 29, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a leading innovator in the cannabidiol (CBD) wellness industry, is proud to announce a...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.04.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Announces Groundbreaking 100MG Full Spectrum CBD Gummy Geared Toward Mental Health & Focus
News Preview
With the global CBD market expected to exceed $60 billion by 2030, and the mental wellness industry surging past $500 billion, CBD Life Sciences Inc. (OTC:CBDL) is strategically positioning itself at the center of two of the fastest-growing markets in modern health. SCOTTSDALE, AZ / ACCESS Newswire / April 22, 2025 / CBD Life Sciences Inc. (OTC PIN...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.04.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Company Online Sales Up 500%
News Preview
With the global wellness industry exploding past $7 trillion, CBDL positions itself at the intersection of CBD, mushrooms, and modern healing - delivering real results and red-hot returns. SCOTTSDALE, AZ / ACCESS Newswire / April 10, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) is thrilled to announce a 500% increase in online sales this past quar...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
01.04.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Powers Forward with Disruptive Brain-Boosting Mushroom Applications
News Preview
The global functional mushroom market is projected to reach $19.3 billion by 2030, driven by cutting-edge research revealing their potential to enhance memory, nerve growth, and overall cognitive health. SCOTTSDALE, AZ / ACCESS Newswire / April 1, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) is making bold strides into the booming functional mushr...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.03.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Launches Passion Fuel Cordyceps Complex - A Powerful Sexual Enhancement Supplement
News Preview
The global sexual wellness market is projected to surpass $125 billion by 2026, with the supplement industry experiencing rapid growth as consumers seek natural solutions for enhanced performance and vitality. SCOTTSDALE, AZ / ACCESS Newswire / March 27, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) is making waves in the booming health and wellnes...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
25.03.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Gears Up for Cave Creek Bike Week 2025
News Preview
CBDL Targets a Multi-Million Dollar Market as Tens of Thousands of Attendees Converge for Arizona's Hottest Motorcycle Event SCOTTSDALE, AZ / ACCESS Newswire / March 25, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a market leader in the CBD and mushroom wellness industry, is revving up for its high-octane presence at the legendary Cave Creek Bik...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.02.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Launches Mushroom Powder Capsules
News Preview
The Global Functional Mushroom Market is Set to Surpass $19 Billion by 2030—CBDL Enters the Booming Industry with Premium Mushroom Capsules for Cognitive Enhancement, Immune Support & Longevity! SCOTTSDALE, ARIZONA / ACCESS Newswire / February 26, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL) is making a bold move into the multi-billi...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.02.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBDL Launches New Mushroom Supplement Drink & Smoothie Bar
News Preview
The functional mushroom industry is exploding, set to surpass $69 billion by 2028, and CBDL is seizing the moment-unlocking a massive revenue opportunity with its latest game-changing expansion. SCOTTSDALE, ARIZONA / ACCESS Newswire / February 19, 2025 / CBD Life Sciences Inc. (OTC:CBDL) is proud to announce a groundbreaking expansion with the gran...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
04.02.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Announces Its Official Launch on Groupon.com
News Preview
Groupon, with over 22.5 million active users and generating more than $550 million in annual revenue, now features CBDL's top-tier wellness products, unlocking massive e-commerce potential and positioning the company for explosive growth in the booming CBD industry. SCOTTSDALE, AZ / ACCESS Newswire / February 4, 2025 / CBD Life Sciences Inc. (OTC P...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.01.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Announces Open Market Share Buyback
News Preview
Company Reports 3.5 billion Share Reduction from the Authorization SCOTTSDALE, AZ / ACCESS Newswire / January 22, 2025 / CBD Life Sciences Inc. (OTC PINK:CBDL), a trailblazer in the CBD and wellness industries, is proud to announce a transformative financial milestone-the successful reduction of its authorized share count by an extraordinary 3.5 bi...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
14.01.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) in Final Stages to Sell CBD Products on DoorDash Platform
News Preview
With DoorDash projecting over $10 billion in 2025 revenue, CBD Life Sciences Inc. is set to tap into one of the fastest-growing delivery markets in the country, potentially unlocking a multi-million dollar revenue stream and driving a projected 30-40% increase in annual revenue for CBDL. SCOTTSDALE, ARIZONA / ACCESSWIRE / January 14, 2025 / CBD Lif...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
07.01.2025
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for Mushroom Supplement, Setting the Stage for Unprecedented Growth
News Preview
Walmart Marketplace saw a 60% year-over-year growth in gross merchandise volume, with third-party sellers accounting for over 50% of online sales, contributing to Walmart's e-commerce revenue surpassing $100 billion in 2024. This makes it a powerful platform for rapid brand growth and a game-changing opportunity for CBDL's breakthrough product line...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
18.12.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Announces 3.5 Billion Share Reduction From the Authorization
News Preview
Demonstrating shareholder confidence, CBDL commits to repurchasing 10% of revenue quarterly. SCOTTSDALE, AZ / ACCESSWIRE / December 18, 2024 / CBD Life Sciences Inc. (OTC Pink:CBDL), a leading innovator in the CBD and wellness industry, is thrilled to announce a significant milestone in its ongoing commitment to delivering shareholder value. The co...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
11.12.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Looking to Acquire a Cannabis Growth License in North Las Vegas
News Preview
Target Acquisition Valued at $10 Million with Projected 2025 Gross Revenue of $5 Million, Positioning CBDL for Explosive Growth in Nevada's Burgeoning Cannabis Market SCOTTSDALE, AZ / ACCESSWIRE / December 11, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a leader in CBD innovation, announces its intent to acquire a cannabis growth license in Nort...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
05.12.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences, Inc. (CBDL) Reports Stunning 622% Revenue Growth From June to November 2024
News Preview
Exploding with momentum: CBDL shatters records with 622% revenue growth in five months, propelling to a 1,405% year-to-date increase-a game-changer in the CBD industry. SCOTTSDALE, ARIZONA / ACCESSWIRE / December 5, 2024 / CBD Life Sciences, Inc. (CBDL), a leading innovator in the CBD industry, is proud to announce an extraordinary 622% increase in...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.12.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Announces New Delta-8 100MG Gummies Designed to Support Individuals Living With Alzheimer’s
News Preview
Targeting a booming $6 billion U.S. edibles market with a projected $3 million in first-year revenue, CBDL delivers an innovative solution for Alzheimer's care. SCOTTSDALE, ARIZONA / ACCESSWIRE / December 3, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a leader in cannabinoid innovation, proudly announces the launch of its groundbreaking Delta-8...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
19.11.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Closes on LOI for Potential $8 Million Revenue Cannabis Dispensary
News Preview
With the New York cannabis market projected to surpass $5 billion by 2027, this acquisition positions CBDL for exponential revenue growth and expanded market dominance.SCOTTSDALE, AZ / ACCESSWIRE / November 19, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a pioneering force in the CBD and cannabis industries, is proud to announce the signing of a...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
13.11.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine
News Preview
Company is creating its own wine. Capitalizing on the projected $2.1 billion U.S. CBD-infused beverage market by 2025, CBDL positions itself at the forefront of innovation, unlocking immense revenue potential in the booming CBD alcohol sector. SCOTTSDALE, AZ / ACCESSWIRE / November 13, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a pioneer in the...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
07.11.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences, Inc. (CBDL) Positioned for Unmatched Growth as Trump Welcomes Weed Legalization and Federal Rescheduling
News Preview
The global cannabis market size was valued at USD 43.72 billion in 2022 and is projected to grow from USD 57.18 billion in 2023 to USD 444.34 billion by 2030, exhibiting a CAGR of 34.03% during the forecast period. North America dominated the global market with a share of 81.79% in 2022.SCOTTSDALE, AZ / ACCESSWIRE / November 7, 2024 / With Former P...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
31.10.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping Into a Booming $20 Billion Market
News Preview
Projected to reach the $20 billion global mushroom market by 2030, CBDL's entry offers shareholders a unique opportunity to capitalize on a sector growing at over 14% annuallySCOTTSDALE, AZ / ACCESSWIRE / October 31, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL) sets a new industry standard with its launch of a high-performance line of mushroom-inf...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
29.10.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High-Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value
News Preview
The global CBD pet care market, which includes products for animals like dogs, cats, and horses, was valued at approximately $125 million in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 40.3% from 2021 to 2028.SCOTTSDALE, AZ / ACCESSWIRE / October 29, 2024 / CBD Life Sciences Inc. (CBDL), an innovative leader in the CBD i...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
24.10.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push
News Preview
With the potential for explosive profits in a $70 billion industry, CBDL's innovative product line and strategic market positioning stand ready to deliver unparalleled returns for shareholders, making this a true game changer in the Hemp market. SCOTTSDALE, AZ / ACCESSWIRE / October 24, 2024 / The U.S. is on the verge of a historic shift. With the...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
22.10.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for 3000MG Pain Relief Cream, Setting the Stage for Unprecedented Growth
News Preview
Walmart's market cap as of September 2024 is $635.50 billion, making it the 13th most valuable company in the world. This partnership offers CBD Life Sciences unprecedented exposure on a global retail platform.SCOTTSDALE, AZ / ACCESSWIRE / October 22, 2024 / CBD Life Sciences, Inc. (OTC PINK:CBDL) proudly announces a monumental step forward in its...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
17.10.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences, Inc. (CBDL) Announces a Staggering 1744.00% Revenue Growth as Innovation and Strategic Expansion Drive Market Dominance
News Preview
As the global CBD market is projected to reach $47 billion by 2028, CBDL's groundbreaking product innovations, retail expansion, and strategic partnerships position the company for unparalleled growth and industry leadership.SCOTTSDALE, AZ / ACCESSWIRE / October 17, 2024 / CBD Life Sciences, Inc. (CBDL), a trailblazer in the rapidly expanding CBD a...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
15.10.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences, Inc. (CBDL) Announces Strategic MOU With U.S. Armed Forces for Groundbreaking Mushroom Supplement
News Preview
CBD Life Sciences propels its expansion with a major MOU, positioning the company for multi-million-dollar growth in the booming $14.6 billion adaptogens market.SCOTTSDALE, AZ / ACCESSWIRE / October 15, 2024 / CBD Life Sciences, Inc. (OTC PINK:CBDL) is excited to announce the signing of a game-changing Memorandum of Understanding (MOU) with a divis...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
10.10.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products
News Preview
Leveraging Alibaba's 1.28 billion annual active consumers and $3 trillion in gross merchandise volume to accelerate growth and global market penetration.SCOTTSDALE, AZ / ACCESSWIRE / October 10, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a trailblazer in the CBD industry, proudly announces a bold new step in its expansion strategy by targeting...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
08.10.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024
News Preview
"Record-breaking revenue, new market entries, and transformative partnerships highlight our path to increasing shareholder value and long-term growth."SCOTTSDALE, AZ / ACCESSWIRE / October 8, 2024 / Dear Shareholders,2024 has been a banner year for CBD Life Sciences, Inc. (CBDL), and we are thrilled to provide you with an exciting corpora...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
03.10.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences, Inc. (CBDL) Launches First-of-Its-Kind CBD Horse Paste: A Veterinarian-Designed Solution for Equine Wellness
News Preview
The annual economic impact of the equine industry is significant - involving some $300 billion dollars and 1.6 million full-time jobs. CBD Life Sciences' Groundbreaking Horse Paste is Set to Transform the Industry and Drive Explosive GrowthSCOTTSDALE, AZ / ACCESSWIRE / October 3, 2024 / CBD Life Sciences, Inc. (CBDL), an industry leader in innovati...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
02.10.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Ignites Expanding Revenue Stream With RangeMe, Poised for Explosive Growth
News Preview
RangeMe connects CBDL to over 200,000 retail buyers, including some of the world's largest retailers, driving exponential market opportunitiesSCOTTSDALE, AZ / ACCESSWIRE / October 2, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a trailblazer in the booming CBD industry, today announces a strategic leap in expanding its revenue channels by partner...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
01.10.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Targets Amazon Marketplace for Strategic Business Enhancements
News Preview
With Amazon's market value increasing by more than $400 billion in 2024, CBD Life Sciences Inc. is poised for new revenue growth with top-selling CBD Pain Relief Roll-On and Pet Treats.SCOTTSDALE, AZ / ACCESSWIRE / October 1, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a fast-growing leader in the CBD industry, is excited to announce its applica...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
26.09.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Inc. (CBDL) Announces Record Revenue Increase of 1405.46% Since February 2024
News Preview
The U.S. CBD consumer health market size was estimated at USD 7.81 billion in 2023 and is projected to surpass around USD 31.11 billion by 2033 at a CAGR of 14.79% from 2024 to 2033 SCOTTSDALE, AZ / ACCESSWIRE / September 26, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), a leading innovator in the CBD and wellness industry, is proud to announce an...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
24.09.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences, Inc. (CBDL) Announces Expanding Revenue Stream With Walmart Marketplace
News Preview
Walmart's market cap as of September 2024 is $635.50 billion, making it the 13th most valuable company in the world. This partnership offers CBD Life Sciences unprecedented exposure on a global retail platform.SCOTTSDALE, AZ / ACCESSWIRE / September 24, 2024 / CBD Life Sciences, Inc. (OTC PINK:CBDL), a leader in innovative cannabidiol products, is...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
17.09.2024
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness
News Preview
Projected to increase company revenue by 20% in the first year, capitalizing on the booming $18 billion wellness market.SCOTTSDALE, AZ / ACCESSWIRE / September 17, 2024 / CBD Life Sciences, Inc. (CBDL), an innovative leader in the CBD wellness industry, is set to launch a cutting-edge nutritional supplement powder designed to harness the powerful h...
Themefolio
Profiler
Peergroup
© Newsfile
24.08.2020
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBDL's LBC Bioscience Inc. Signs Exclusive Agreement for Manufacturing of CBD Biodegradable Drinking Straws for B2B and B2C Distribution
News Preview
Scottsdale, Arizona--(Newsfile Corp. - August 24, 2020) - CBD Life Sciences Inc. (OTC PINK: CBDL) ("The Company") wholly owned subsidiary, LBC Bioscience Inc. ("LBC") has signed an exclusive Agreement with a Phoenix, Arizona based Cannabis, Hemp and CBD Laboratory to manufacture CBD lined drinking straws which the Company anticipates will be a firs...
Themefolio
Profiler
Peergroup
© Newsfile
21.07.2020
ISIN: US12482V1035

CBD Life Sciences Inc.
CBDL

LISTED

OTC
CBD Life Sciences Announces Entry into Rapidly Growing CBD Vending Space with Acquisition and Placement of CBD Vending Machines in Arizona and Nevada
News Preview
Scottsdale, Arizona--(Newsfile Corp. - July 21, 2020) - CBD Life Sciences Inc. (OTC PINK: CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. is pleased to announce that the Company has moved forward with an initial order of CBD vending machines it will begin deployment of in key territories in Arizona and Nevada, to start. Locations w...
Themefolio
Profiler
Peergroup

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2026 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2026 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Saturday, 17.01.2026, Calendar Week 03, 17th day of the year, 348 days remaining until EoY.